Yolatin 6 mg/0,4 mg tablete s prilagođenim oslobađanjem
| Name | Yolatin 6 mg/0,4 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-882007648 |
| Active Substance | solifenacinsukcinat tamsulozinklorid |
| Composition | jedna tableta sadrži 6 mg solifenacinsukcinata, što odgovara 4,5 mg solifenacina i 0,4 mg tamsulozinklorida, što odgovara 0,37 mg tamsulozina |
| Pharmaceutical Form | Tableta s prilagođenim oslobađanjem |
| Manufacturer | Synthon BV, Nijmegen, Nizozemska
Synthon Hispania S.L., Sant Boi de Llobregat, Španjolska Synthon s.r.o., Blansko, Češka |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 16.05.2023 |
| MA Period of Validity | 16.05.2028 |
| Classification Number | UP/I-530-09/21-01/105 |
| Registration Number | 381-12-01/70-23-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04CA53 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
